Transcutaneous Bilirubin Levels in the First 96 Hours in a Normal Newborn Population of > or = 35 Weeks' Gestation
Overview
Authors
Affiliations
Objective: To obtain transcutaneous bilirubin (TcB) measurements, at 6-hour intervals, in the first 96 hours after birth in a normal newborn population (gestational age: > or =35 weeks).
Methods: We performed 9397 TcB measurements on 3984 healthy newborn infants (gestational age: > or =35 weeks) from 6 to 96 hours of age. All measurements were performed in the well-infant nursery with a Draeger Air-Shields transcutaneous jaundice meter (model JM-103), within 2 hours of the designated time.
Results: There was a distinct pattern to the velocity of the increase in TcB levels over different time periods. TcB levels increased in a linear manner most rapidly in the first 6 to 18 hours and then less rapidly from 18 to 42 hours, followed by a much slower increase until peak levels occurred. Decreasing gestational age was associated significantly with higher TcB levels.
Conclusions: We provide data on neonatal bilirubinemia, based on TcB levels determined in a large, predominately white and breastfed, North American population. Infants who require closer evaluation and observation initially are those whose bilirubin levels are > or =95th percentile, ie, increasing more rapidly than 0.22 mg/dL per hour in the first 24 hours, 0.15 mg/dL per hour between 24 and 48 hours, and 0.06 mg/dL per hour after 48 hours. These data should be useful for detecting aberrant trends, identifying infants who need additional evaluation, and planning appropriate follow-up for jaundiced newborns.
Casnocha Lucanova L, Zibolenova J, Matasova Jr K, Matasova K, Zibolen M Front Public Health. 2023; 11:1212667.
PMID: 37538268 PMC: 10395091. DOI: 10.3389/fpubh.2023.1212667.
Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns.
Okwundu C, Olowoyeye A, Uthman O, Smith J, Wiysonge C, Bhutani V Cochrane Database Syst Rev. 2023; 5:CD012660.
PMID: 37158489 PMC: 10167941. DOI: 10.1002/14651858.CD012660.pub2.
Elmassry M, Kim S, Busby B PLoS One. 2021; 16(1):e0244876.
PMID: 33411719 PMC: 7790408. DOI: 10.1371/journal.pone.0244876.
Predictive Models for Neonatal Follow-Up Serum Bilirubin: Model Development and Validation.
Chou J JMIR Med Inform. 2020; 8(10):e21222.
PMID: 33118947 PMC: 7661258. DOI: 10.2196/21222.
Turkish Neonatal Society guideline to the approach, follow-up, and treatment of neonatal jaundice.
Coban A, Kaynak Turkmen M, Gursoy T Turk Pediatri Ars. 2019; 53(Suppl 1):S172-S179.
PMID: 31236030 PMC: 6568284. DOI: 10.5152/TurkPediatriArs.2018.01816.